Diabetic foot ulcer burden may be modified by high‐dose atorvastatin: A 6‐month randomized controlled pilot trial

OE Johansen, KI Birkeland, AP Jørgensen… - Journal of …, 2009 - Wiley Online Library
Abstract Background: Diabetic foot ulcers (DFUs) are common complications of diabetes
mellitus (DM), with a complex pathogenesis. Treatment is difficult and no single treatment …

Statins may be associated with six‐week diabetic foot ulcer healing

JD Fox, KL Baquerizo‐Nole… - Wound Repair and …, 2016 - Wiley Online Library
Diabetic foot ulcers (DFUs) affect 1.5 million Americans annually, of which only a minority
heal with standard care, and they commonly lead to amputation. To improve care …

[HTML][HTML] Risk factors of diabetic foot ulcer in patients with type 2 diabetes: a retrospective cohort study

W Ouyang, Y Jia, L Jin - American Journal of Translational …, 2021 - ncbi.nlm.nih.gov
The aim of this study is to investigate the risk factors of diabetic foot ulcer (DFU) in patients
with Type 2 diabetes. Baseline characteristics of DFU-free patients with Type 2 diabetes …

Lipid-lowering therapy in the diabetic foot: seeing the whole iceberg and not just the tip

C Antonoglou, N Papanas… - Current Vascular …, 2014 - ingentaconnect.com
Diabetic foot ulcers arise from neuropathy and/or ischaemia. The diabetic foot is associated
with cardiovascular disease (CVD) and excess mortality. Lipid-lowering therapy reduces …

Risk factors for the recurrence of diabetic foot ulcers among diabetic patients: a meta‐analysis

ZH Huang, SQ Li, Y Kou, L Huang… - International wound …, 2019 - Wiley Online Library
This study aimed to systematically review and identify the risk factors for the recurrence of
diabetic foot ulcers (DFUs) among diabetic patients. PUBMED, EMBASE, Web of Science …

Previous Atorvastatin Treatment and Risk of Diabetic Foot Infection in Adult Patients: A Case-control Study.

M Nassaji, R Ghorbani - … a Compendium of Clinical Research and …, 2017 - europepmc.org
Objective In addition to their lipid-lowering abilities, statins have anti-inflammatory and
immunomodulatory properties. Increasing recent evidence suggests the possible role of …

Diabetic foot ulcers. Pathophysiology, assessment, and therapy.

CK Bowering - Canadian Family Physician, 2001 - cfp.ca
OBJECTIVE To review underlying causes of diabetic foot ulceration, provide a practical
assessment of patients at risk, and outline an evidence-based approach to therapy for …

Decreasing incidence of foot ulcer among patients with type 1 and type 2 diabetes in the period 2001–2014

A Rasmussen, T Almdal, AA Nielsen, KE Nielsen… - diabetes research and …, 2017 - Elsevier
Aim Diabetic foot ulcer (DFU) is a serious complication to diabetes. The aim was to study the
incidence of first DFU among patients with type 1 (T1DM) and type 2 diabetes (T2DM) …

Associated risk factors and management of chronic diabetic foot ulcers exceeding 6 months' duration

H Gubara Musa, M E. Ahmed - Diabetic foot & ankle, 2012 - Taylor & Francis
Background: The management of chronic diabetic foot ulcers (DFU) poses a great challenge
to the treating physician and surgeon. The aim of this study was to identify the risk factors …

The pathway to foot ulceration in diabetes

AJM Boulton - Medical Clinics, 2013 - medical.theclinics.com
Foot ulcers in diabetic patients are common but eminently preventable, and occur in both
main types of diabetes. From a global perspective, although diabetic foot ulcers (DFU) are …